Last Week’s Best Healthcare ETF
In fact, the majority of the most popular exchange-traded funds that focus on healthcare stocks had a great week and posted positive returns. Several of these ETFs were even up by more than 3%, but that still wasn’t good enough to match the best-performing … Continue reading at fool.com
Mid-Day ETF Update: ETFs, Stocks Higher as Crude Oil Prices Rally, Upstaging Weak Inventories Data
Broad-market exchange-traded funds, including SPY, IWM, IVV and others, were firmer. Meanwhile, actively traded PowerShares QQQ (QQQ) is down 0.2%. U.S. stocks were in positive territory at the session’s half following a rally in oil, as well as upbeat … Continue reading at nasdaq.com
JPMorgan Expands ETF Lineup With 2 Currency-Hedged Funds
JPMorgan Chase & Co. (NYSE: JPM)’s J.P. Morgan Asset Management expanded its lineup of exchange traded funds Monday with the addition of two currency hedged funds. The JPMorgan Diversified Return Europe Currency Hedged Equity ETF (NYSE: JPEH) and the … Continue reading at money.cnn.com
Stock ETFs Add Sixth Week to Streak of Inflows: Lipper
Exchange-traded fund investors showed continued confidence in U.S. markets, delivering stock ETFs based in the country $ 3.5 billion and their sixth straight week of net new cash during the latest week, Lipper data showed on Thursday. Continue Reading Below … Continue reading at foxbusiness.com
Outperforming Small-Cap ETF Strategies
Within the small-cap asset category, exchange traded funds that track alternative or smart-beta indexing methodologies have been standouts. The widely observed iShares Russell 2000 ETF (NYSEArca: IWM), which tracks the Russell 2000 Index, has rallied 16.2% … Continue reading at etftrends.com
John C. Bogle, founder of The Vanguard Group of Investment Companies, is both a dynamic leader in the mutual fund industry and its…
Pozen, a leading industry expert, offers a structured presentation of mutual funds for upper-level undergraduates and MBA students…
Discover The Essential Strategies to Make Investing in Mutual Funds Profitable
Today only, get this Kindle book for just $2.99. R…
The Globe and Mail's ETF Buyer's Guide, Part 2: U.S. equity
The argument that exchange-traded funds are the simplest way to invest is never more tested than when you want exposure to U.S. stocks. You have all the usual factors to consider when comparing U.S. equity ETFs - fees, diversification and trading volumes … Continue reading at theglobeandmail.com
J.P. Morgan Now Offers Two New Strategic Beta ETFs (JPM)
The asset management arm of J.P. Morgan Chase & Co. (JPM) recently added two new exchange-traded funds (ETFs) to its offering of strategic beta funds by launching JPMorgan Diversified Return Europe Currency Hedged Equity ETF (JPEH) and JPMorgan Diversified … Continue reading at investopedia.com
Here's Why You Should Stay Away From Gold ETFs
On March 4, BlackRock, the sponsor of the gold ETF iShares Gold Trust (IAU), announced it had temporarily suspended issuance of new shares in the fund. The sponsor admitted it had failed to register the new shares with the SEC as exchange traded commodity … Continue reading at valuewalk.com
Do ETFs’ Flows Drive the Gold Price?
What are ETFs? The ETFs, or Exchange-Traded Funds, are funds that track indices, commodities or securities. The ETF shares are securities that closely resemble the yield and return of its native index, but - unlike mutual funds units - can be traded … Continue reading at fxstreet.com
* Investing made simple: The Motley Fool’s essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource was designed to cover everything that new investors need to know to get started today. For your free copy, just click the link above.
There has been a lot of buzz in recent days about the idea of a bubble in the biotech space on the market today. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB), an ETF that tracks a range of companies in the biotech space, peaked exactly a month ago, and has since lost 12% of its value, falling 3% in a single day yesterday. Investors are understandably concerned that the sell-off will lead to a continued decline in the days ahead.
In this video, Motley Fool healthcare analyst David Williamson discusses why there may be some validity to the speculation of a bubble in this sector at the moment. David then gives investors his three top picks for which companies he would jump in on if a biotech pullback offered a lower price point, and why these three pharmaceutical businesses have the underlying strength to survive any market condition.
Visit us on the web at http://www.fool.com, home to the world’s greatest investing community!
Subscribe to The Motley Fool’s YouTube Channel:
Or, follow our Google+ page:
Inside The Motley Fool: Check out our Culture Blog!
Join our Facebook community:
Follow The Motley Fool on Twitter:
Tweets by themotleyfool